Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 1/20 | 1.00 |
| ▸ | GBA1 | P04062 | 4/20 | 0.50 |
| ▸ | MGAM | O43451 | 6/20 | 0.33 |
| ▸ | FUCA1 | P04066 | 5/20 | 0.33 |
| ▸ | GLA | P06280 | 2/20 | 0.33 |
| ▸ | GANC | Q8TET4 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Scyllitol SCHEMBL12411898 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL6378921 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL4447990 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL4438767 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL12377889 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL21388397 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL5969 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL959405 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL188237 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL188106 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106579282-B | Organic compounds | 奇华顿股份有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-103313611-B | organic compounds | 奇华顿股份有限公司 | 2018-05-08 | — | — | CN | claimed |
| US-9596874-B2 | Bitter taste masking compositions and method of masking bitter taste | GIVAUDAN S.A. (CH) | 2017-03-21 | — | — | US | claimed |
| EP-2645881-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2014-07-02 | — | — | EP | claimed |
| US-20130309381-A1 | Organic Compounds | GIVAUDAN S.A. (CH) | 2013-11-21 | — | — | US | claimed |
| EP-2645881-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2013-10-09 | — | — | EP | claimed |
| WO-2012072701-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2012-06-07 | — | — | WO | claimed |
| US-6310161-B1 | ACRYLATE WITH MONOTHIOL AND CONJUGATED AROMATIC COMPOUND | UCB S.A. (BE) | 2001-10-30 | — | — | US | claimed |
| EP-0810992-B1 | SULFUR-CONTAINING COMPOUNDS FOR OPTICAL GRADE POLYMERIC CASTING COMPOSITIONS | UCB SA (BE) | 2001-06-13 | — | — | EP | claimed |
| US-6051733-A | Sulfur-containing compounds for optical grade polymeric casting compositions | UCB, S.A. (BE) | 2000-04-18 | — | — | US | claimed |
| EP-0810992-A1 | SULFUR-CONTAINING COMPOUNDS FOR OPTICAL GRADE POLYMERIC CASTING COMPOSITIONS | U C B, S.A. (BE) | 1997-12-10 | — | — | EP | claimed |
| WO-1996026184-A1 | SULFUR-CONTAINING COMPOUNDS FOR OPTICAL GRADE POLYMERIC CASTING COMPOSITIONS | UCB, S.A. (BE) | 1996-08-29 | — | — | WO | claimed |
| EP-4504883-B1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12594346-B2 | Crosslinked hydrogel for immune checkpoint blockade delivery | GEORGIA TECH RESEARCH CORPORATION (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250339581-A1 | SYNTHETIC HYDROGEL CARRIERS FOR MUSCLE REPAIR | GEORGIA TECH RES INST (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250270412-A1 | RADIATION-CURABLE INKJET INK COMPOSITION | CANON PRODUCTION PRINTING HOLDING B.V. (NL) | 2025-08-28 | — | — | US | disclosed |
| WO-1996026184-A1 | SULFUR-CONTAINING COMPOUNDS FOR OPTICAL GRADE POLYMERIC CASTING COMPOSITIONS | UCB, S.A. (BE) | 1996-08-29 | — | — | WO | disclosed |
| US-4230845-A | X-RAY CONTRAST AGENTS | MALLINCKRODT, INC. (US) | 1980-10-28 | — | — | US | disclosed |
| US-4125709-A | X-RAY CONTRAST AGENTS | MALLINCKRODT, INC. (US) | 1978-11-14 | — | — | US | disclosed |
| US-4080364-A | Stabilization of polyolefins against degradative deterioration as a result of exposure to light and air at elevated temperatures | ARGUS CHEMICAL CORPORATION (US) | 1978-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594346-B2 | Crosslinked hydrogel for immune checkpoint blockade delivery | CD274, PDCD1, IL2 | LMNA 4654/4885APP 3719/4885GBA1 3661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.